Our vaccines against the different serotypes of Bluetongue virus
A TOOL OF PREVENTION
BLUEVAC is an essential tool in the control of Bluetongue virus (serotype 1, 4 and 8) in sheep and cattle, producing an active immunization and decreasing the spread of the disease.
ADVANCED TECHNOLOGY OF ADJUVANTS
BLUEVAC is based on the use of Aluminum hydroxide and Quil A as adjuvants. Quil A is a derivative of a purified saponin that repositions viral antigens and retards them, so they are captured by immunity cells from vaccinated animals.
Testing and validated by RT-PCR method, BLUEVAC BTV prevents viraemia, indicating no presence of viral genome after vaccination and is safe.
LESS LOCAL REACTIONS
The use of the purified Saponin Quil A as an adjuvant produces no serious local reactions.
- Control of the appearance of clinical cases of Bluetongue disease
- Cost-benefit of one dose vs losses associated with clinical signs and decreased production
- Control of the dissemination of the disease and declining trade restrictions
More than 230 million doses of BLUEVAC BTV administered in Europe, have shown to be a valuable method and the best choice to reduce clinical signs and viraemia in sheep and cattle herds.
DECREASES THE PREVALENCE OF BLUETONGUE
Vaccination with BLUEVAC BTV prevents viraemia and transmission to healthy animals, decreasing the prevalence of the disease in endemic areas.
With a collapsible plastic bottle, BLUEVAC BTV has a stronger and lighter packaging, and does not require vented draw-of equipment.